6 results
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
Summary of dosing ... recommendations in renal ... #Pharmacology # ... Renal #Impairment ... #CKD #Table #GFR
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
- Pharmacology ... Summary Mechanisms ... Contraindications: eGFR ... #Pharmacology # ... Summary #DM2 #diabetes
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
DPP-4 Inhibitors ... - Pharmacology ... Summary Mechanisms ... #Pharmacology # ... Summary #DM2 #diabetes
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
- Normal and Renal ... Dosing Increase ... #Renal #Dosing ... #Pharmacology #Management ... #Diabetes #DM2
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
α-glucosidase inhibitor ... insulin dose for renal ... #Mellitus #DM2 ... #Medications #pharmacology ... #comparison #table
Hyperkalemia - Diagnosis and Management - GrepMed Handbook

S/Sx: Most pts asymptomatic. Weakness, cramping, nausea, paresthesias, palpitations,
infusion, Calcineurin inhibitors ... transfusions), ↓insulin (DM ... Excretion: - Renal ... 15 suggests ↓ renal ... Elimination (see Table